AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Organigram Global Inc.
Video analysis: OGI
All videosNo video analysis for this stock yet. Request one from our team.
News: OGI
Organigram Global to Host 2026 OG Investor Session
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the "Company" or "Organigram"), Canada's #1 cannabis company by market share and a growing global cannabis platform, today announced details of its 2026 OG Investor Session. “Since our last investor session, we've welcomed a new leadership team, completed our first full quarter with Sanity Group, and sharpened our strategy for the years ahead. We look forward to updating our stakeholders on how we're aligning Organigram.
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (âOrganigramâ or the âCompanyâ) today announced an important milestone in its global growth strategy thr
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram” or the “Company”) today announced an important milestone in its global growth strategy through the accelerated integration of Sanity Group GmbH (“Sanity”) and the alignment of leadership, operations and market development activities across the combined organization. To support the combined organization, Organigram has appointed Finn Age Hänsel as President, Rest of World & Chief Strategy Officer, and Adr.
OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.03 per share a year ago.
Organigram Global Q3 Earnings Call Highlights
Organigram Global NASDAQ: OGI reported record third-quarter fiscal 2026 revenue and adjusted EBITDA, aided by the consolidation of Germany-based Sanity Group and improving performance in several Canadian cannabis categories.
Organigram Reports Record Third Quarter Fiscal 2026 Results
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share2 and a growing global cannabis platform following its acquisition of Sanity Group GmbH (“Sanity” or “Sanity Group”), today announced its results for the third quarter ended June 30, 2026 (“Q3 Fiscal 2026” or “Q3”). Q3 FISCAL 2026 HIGHLIGHTS Gross Revenue: $145.1 million (+32% year-over-year). Net Revenue: $105.8 million (+49% year-over-year). A.
Organigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity Group GmbH (“Sanity”), announced today it will report earnings results for its third quarter ended June 30, 2026, on Tuesday, August 11, 2026, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, Aug.
Organigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market Share
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share and a growing global cannabis platform following its acquisition of Sanity Group GmbH (“Sanity”), today provided a business update highlighting initial operating performance from Sanity, continued strength in its Canadian business, and upcoming investor engagement. "The first quarter following the acquisition of Sanity marks an important milest.
Similar companies
-
Journey Medical Corporation
DERM
·
NASDAQ
Compare
-
InfuSystem Holdings, Inc.
INFU
·
New York Stock Exchange Arca
Compare
-
Aurora Cannabis Inc.
ACB
·
NASDAQ
Compare
-
Solana Company
HSDT
·
NASDAQ
Compare
-
Cartesian Therapeutics, Inc.
RNAC
·
NASDAQ
Compare
-
Orchestra BioMed Holdings, Inc.
OBIO
·
NASDAQ
Compare